Additional coverage: You can also read or listen to a full Q&A with Advocate BroMenn President Colleen Kannaday, airing Friday on WGLT's Sound Ideas.
Advocate BroMenn Medical Center in Normal and Advocate Eureka Hospital are changing hands. Urbana-based Carle will acquire BroMenn and Eureka.
Advocate and Carle noted Carle's "strong local footprint and a proven track record of successful partnership, enhanced access and coordination of care, and services for patients in Central Illinois as key drivers for the transaction" in a news release Thursday.
Advocate has been aggressively expanding its network for years but appears to be now concentrating on areas north of central Illinois. Advocate BroMenn and Eureka had been the southernmost healthcare operation in Advocate's portfolio of hospitals.
In 2018 Advocate merged with Aurora Healthcare, a large network of providers in Wisconsin.
Advocate BroMenn President Colleen Kannaday will remain in charge of the BroMenn-Eureka facilities.
“We look forward to welcoming Advocate BroMenn, Eureka, the Medical Group and other clinical teams to Carle. Our providers, hospitals and health plan have long partnered to deliver care through joint services, referrals and health coverage. We believe that coming together will allow us to use the strengths of our organizations to offer new programs to serve the region,” said Dr. James C. Leonard, Carle president and chief executive officer.
“Our consumers are at the center of everything we do and sometimes we must look outside our walls to best serve their needs,” said Jim Skogsbergh, president and chief executive officer of Advocate Aurora Health. “Carle is a well-respected, financially-strong provider who shares our commitment to excellence, and we are fully confident they will serve our talented team members, physicians and communities well. It’s been a privilege to serve the great people and communities in Central Illinois and we are committed to a smooth transition for all.”
Both the Advocate Aurora and Carle governing boards approved the plan, announcing the decision to physicians, nurses and team members in both organizations Thursday.
Terms of the transaction are not being disclosed. The transaction is subject to regulatory approval, including by the Illinois Health Facilities and Services Review Board and the Federal Trade Commission.
Both organizations say they expect the deal to close in 2020 and that patient care will not be affected.
People like you value experienced, knowledgeable and award-winning journalism that covers meaningful stories in Bloomington-Normal. To support more stories and interviews like this one, please consider making a contribution.
